Read twice and referred to the Committee on the Judiciary.
The bill amends the Office of National Drug Control Policy Act to add HIDTA reporting and assessment requirements focused on fentanyl. It authorizes $333 million annually for HIDTA FY2025–2030, increases a stated program amount to $14,224,000, and expands HIDTA purposes to include fentanyl interdiction support.
Progressives emphasize treatment, civil‑rights risks versus criminalization concerns.
Targeted law-enforcement bill with measurable deliverables and likely cross-aisle appeal; spending authorization may trigger appropriations scrutiny.
The bill amends the Office of National Drug Control Policy Act to add HIDTA reporting and assessment requirements focused on fentanyl.
It authorizes $333 million annually for HIDTA FY2025–2030, increases a stated program amount to $14,224,000, and expands HIDTA purposes to include fentanyl interdiction support.
It requires annual reports on HIDTA-funded fentanyl investigations and regional threat data, directs HIDTAs to report limitations and recommendations, and instructs the Attorney General to provide temporary assistant U.S. attorney reassignments for fentanyl prosecutions, with a 180‑day process deadline.
Moderate chance: practical, limited-scope enforcement measures attract support, but explicit funding and DOJ mandates create appropriation and oversight objections.
How solid the drafting looks.
Progressives emphasize treatment, civil‑rights risks versus criminalization concerns.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize treatment, civil‑rights risks versus criminalization concerns.
Views the bill as a law-enforcement–focused response to fentanyl that provides data and resources.
Likely welcomes better data on fentanyl trafficking but worries about emphasis on prosecution over public health.
Concerns about civil liberties, racial disparities, and opportunity cost versus treatment and harm reduction are likely.
Sees the bill as a pragmatic strengthening of interdiction tools and information for HIDTAs, addressing a national overdose driver.
Appreciates reporting and resource clarity but wants cost oversight, measurable outcomes, and coordination with public-health responses.
Likely supportive with conditions for accountability.
Views the bill favorably as strengthening law‑and‑order responses to fentanyl trafficking.
Appreciates new funding, prosecutorial resources, and clearer HIDTA authority to interdict dangerous substances.
May seek even tougher enforcement or faster implementation, but generally supportive.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderate chance: practical, limited-scope enforcement measures attract support, but explicit funding and DOJ mandates create appropriation and oversight objections.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize treatment, civil‑rights risks versus criminalization concerns.
Moderate chance: practical, limited-scope enforcement measures attract support, but explicit funding and DOJ mandates create appropriation…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for HIDTA Enhancement Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.